BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11596990)

  • 1. Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases.
    Eng CM; Desnick RJ
    Adv Genet; 2001; 44():275-96. PubMed ID: 11596990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal genetic screening in the Ashkenazi Jewish population.
    Zinberg RE; Kornreich R; Edelmann L; Desnick RJ
    Clin Perinatol; 2001 Jun; 28(2):367-82. PubMed ID: 11499058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.
    Ferreira JC; Schreiber-Agus N; Carter SM; Klugman S; Gregg AR; Gross SJ
    Am J Obstet Gynecol; 2014 Sep; 211(3):197-204. PubMed ID: 24508465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.
    Scott SA; Edelmann L; Liu L; Luo M; Desnick RJ; Kornreich R
    Hum Mutat; 2010 Nov; 31(11):1240-50. PubMed ID: 20672374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-based carrier screening in the Ashkenazi Jewish population.
    Zhang B; Dearing L; Amos J
    Expert Rev Mol Diagn; 2004 May; 4(3):377-92. PubMed ID: 15137904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ashkenazi Jewish genetic disorders.
    Charrow J
    Fam Cancer; 2004; 3(3-4):201-6. PubMed ID: 15516842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendation of premarital genetic screening in the Syrian Jewish community based on mutation carrier frequencies within Syrian Jewish cohorts.
    Zeevi DA; Chung WK; Levi C; Scher SY; Bringer R; Kahan Y; Muallem H; Benel R; Hirsch Y; Weiden T; Ekstein A; Ekstein J
    Mol Genet Genomic Med; 2021 Aug; 9(8):e1756. PubMed ID: 34288589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease-causing variants.
    Shi L; Webb BD; Birch AH; Elkhoury L; McCarthy J; Cai X; Oishi K; Mehta L; Diaz GA; Edelmann L; Kornreich R
    Clin Genet; 2017 Apr; 91(4):599-604. PubMed ID: 27415407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients.
    Akler G; Birch AH; Schreiber-Agus N; Cai X; Cai G; Shi L; Yu C; Larmore AM; Mendiratta-Vij G; Elkhoury L; Dillon MW; Zhu J; Mclellan AS; Suer FE; Webb BD; Schadt EE; Kornreich R; Edelmann L
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1053. PubMed ID: 31880409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening.
    Grinzaid KA; Page PZ; Denton JJ; Ginsberg J
    J Genet Couns; 2015 Jun; 24(3):381-7. PubMed ID: 25502003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating yields of prenatal carrier screening and implications for design of expanded carrier screening panels.
    Guo MH; Gregg AR
    Genet Med; 2019 Sep; 21(9):1940-1947. PubMed ID: 30846881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selected genetic disorders affecting Ashkenazi Jewish families.
    Weinstein LB
    Fam Community Health; 2007; 30(1):50-62. PubMed ID: 17149032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quest for the perfect baby: why do Israeli women seek prenatal genetic testing?
    Remennick L
    Sociol Health Illn; 2006 Jan; 28(1):21-53. PubMed ID: 16509941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.
    Zuckerman S; Lahad A; Shmueli A; Zimran A; Peleg L; Orr-Urtreger A; Levy-Lahad E; Sagi M
    JAMA; 2007 Sep; 298(11):1281-90. PubMed ID: 17878420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier screening for Gaucher disease in couples of mixed ethnicity.
    Wallerstein R; Starkman A; Jansen V
    Genet Test; 2001; 5(1):61-4. PubMed ID: 11336404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of carrier frequencies utilizing the gnomAD database for ACMG recommended carrier screening and Finnish disease heritage conditions in non-Finnish European, Finnish, and Ashkenazi Jewish populations.
    Kandolin M; Pöyhönen M; Jakkula E
    Am J Med Genet A; 2024 Jul; 194(7):e63588. PubMed ID: 38459613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
    Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
    Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier screening panels for Ashkenazi Jews: is more better?
    Leib JR; Gollust SE; Hull SC; Wilfond BS
    Genet Med; 2005 Mar; 7(3):185-90. PubMed ID: 15775754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.